Ensysce Biosciences
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About Ensysce Biosciences
Ensysce Biosciences, Inc. 是一家臨床階段的製藥公司，在美國從事開發各種處方藥，以緩解阿片類藥物成癮、誤用、濫用和過量的嚴重疼痛。它使用 Trypsin Activated Abuse Protection 平台開發產品，這是一種抗濫用的阿片類藥物前藥技術； Multi-Pill Abuse Resistance 平台，一種過量保護阿片類藥物前藥技術。公司正在開發 PF614，一種羥考酮的 TAAP 前藥候選藥物，目前正處於治療急性或慢性疼痛的 II 期臨床試驗階段；和 PF614-MPAR，PF614 和萘莫司他的組合產品，正在進行 I 期臨床試驗，用於防止過量口服攝入，以及萘莫司他的口服和吸入藥物產品，用於治療冠狀病毒感染和其他肺部疾病，例如囊性纖維化。它還在開發 PF329，一種類似於 PF614 的氫嗎啡酮緩釋前藥； PF8001 和 PF8026 是用於治療 ADHD 藥物濫用的苯丙胺的緩釋和速釋前藥；和 PF26810，一種用於治療阿片類藥物使用障礙的美沙酮緩釋前藥。該公司位於加利福尼亞州拉霍亞。
如何購買 Ensysce Biosciences (ENSC)
登入
1分鐘開戶
僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助，支援 RockFlow App 和網頁端操作。
充值資金
帳戶驗證完成後，您可以使用首選的支付方式向帳戶充值。
購買 ENSC
透過 RockFlow App 或網頁端搜尋 ENSC，輸入您想要投資的金額，然後點擊確認即可完成交易。
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.